急性轻度寒冷暴露伴寒战可降低2型糖尿病患者24小时血糖水平,但糖尿病前期无此效应
该随机交叉试验纳入糖尿病前期12例与稳定2型糖尿病12例,受试者接受轻度(15°C)与中度(4°C)全身寒冷暴露。2型糖尿病组轻度寒冷后24小时平均血糖降低0.6±0.5 mmol/l(p=0.003),糖尿病前期组两种强度均无变化,中度寒冷对2型糖尿病血糖也无显著影响。
要点
- 轻度寒冷伴寒战可降低2型糖尿病24小时平均血糖与空腹血糖
- 糖尿病前期人群未观察到血糖改善
- 基线空腹血糖、年龄和ALT水平可预测降糖反应
核心结论
- 急性轻度寒冷暴露伴寒战可降低2型糖尿病患者的24小时血糖水平,糖尿病前期无变化,效应似取决于基线代谢状态而非寒冷期间的底物利用。
研究设计与样本
- 随机交叉试验,在荷兰South Limburg/Maastricht地区开展,纳入糖尿病前期12例与稳定2型糖尿病12例,年龄40-75岁,BMI≥27且≤35 kg/m2,非吸烟久坐的男性与绝经后女性。
- 受试者接受两次全身寒冷暴露(水灌注服),目标为使静息代谢率(RMR)升高约1.5倍(轻度,15°C)与约2.5倍(中度,4°C),顺序随机化,受试者对强度设盲而研究者未设盲。
- 采用连续血糖监测评估每次干预前后24小时组织间液葡萄糖,饮食与活动受控,寒战经间接测热法与肌电图确认。
主要发现
- 两个研究组、两个暴露期RMR均较基线显著升高(p<0.001)。
- 糖尿病前期组寒冷最后1小时RMR为轻度1.53倍、中度1.94倍;2型糖尿病组分别为轻度1.57倍、中度2.09倍。
- 糖尿病前期组轻度和中度寒冷均未改变24小时平均血糖。
- 2型糖尿病组轻度寒冷后24小时平均血糖降低0.6±0.5 mmol/l(p=0.003),空腹血糖降低0.6±0.8 mmol/l(p=0.019),正常范围时间增加8.8±10.3%(p=0.013),高血糖时间减少10.9±12.9%(p=0.014)。
- 2型糖尿病组中度寒冷对任何血糖结局均无显著影响。
关键数值与推荐
- 2型糖尿病组轻度寒冷后24小时平均血糖变化-0.6±0.5 mmol/l(p=0.003),空腹血糖-0.6±0.8 mmol/l(p=0.019)。
- 正常范围时间+8.8±10.3%(p=0.013),高血糖时间-10.9±12.9%(p=0.014)。
- 基线空腹血糖、年龄和ALT水平为降糖反应的预测因素,基线血糖更高、更年轻和/或ALT更低(肝脏健康更佳)者获益可能更大。
临床怎么用
- 寒冷暴露可能作为2型糖尿病的辅助非药物疗法,轻度强度即可,中度寒冷未见额外血糖获益。
- 效果可能更多见于基线血糖较高、较年轻、ALT较低的患者,糖尿病前期人群暂不支持此干预。
局限性
- 样本量小(每组12例),需更大队列验证。
- 作者指出仍需进一步机制研究;受试者对寒冷强度设盲而研究者未设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Repeated cold exposure with shivering has been proposed as a potential strategy to enhance glucose metabolism by increasing energy expenditure and substrate utilisation. However, acute effects/benefits of cold-induced shivering on glucose homeostasis in metabolically compromised individuals are unknown. Here, we aimed to determine whether cold exposure at two different intensities improves 24 h glucose homeostasis in individuals with prediabetes and type 2 diabetes. METHODS: In a randomised crossover trial conducted in the South Limburg/Maastricht region of the Netherlands, men and postmenopausal women with prediabetes (n=12) and stable type 2 diabetes (n=12), aged 40-75 years, body mass index ≥27 and ≤35 kg/m2, non-smoking and sedentary, underwent two whole-body cold exposure sessions using a water-perfused suit. Session order was randomised using an online randomisation tool (randomizer.org); participants were masked to the cold exposure intensity received, but investigators were not. Sessions were designed to elicit ~1.5-fold (mild, 15°C) and ~2.5-fold (moderate, 4°C) increases in resting metabolic rate (RMR). Continuous glucose monitoring assessed interstitial glucose concentrations over 24 h periods before and after each intervention, with controlled diet and activity. Shivering was confirmed via indirect calorimetry and electromyography. RESULTS: In both study groups and periods, RMR increased significantly vs baseline (p<0.001 for all). In prediabetes, the increase in the final 1 h of cold was 1.53 × RMR in mild and 1.94 × RMR in moderate cold. In type 2 diabetes, the increase was 1.57 × RMR and 2.09 × RMR in the final 1 h of mild and moderate cold, respectively. In prediabetes, neither mild nor moderate cold exposure altered mean 24 h glucose levels. In contrast, after mild cold exposure the type 2 diabetes group exhibited a significant reduction in mean 24 h glucose levels (-0.6 ± 0.5 mmol/l, p=0.003) and fasting glucose (-0.6 ± 0.8 mmol/l, p=0.019), as well as an increase in time in normal range (+8.8 ± 10.3%, p=0.013) and reduced time in hyperglycaemia (-10.9 ± 12.9%, p=0.014). Moderate cold did not significantly affect any of the glucose outcomes in type 2 diabetes. Baseline fasting glucose, age and ALT levels were predictors of the glucose-lowering response, suggesting greater benefits in individuals who have higher baseline glucose levels, are younger and/or have more optimal liver health, i.e. lower ALT. CONCLUSIONS/INTERPRETATION: Acute mild cold exposure with shivering reduced 24 h glucose levels in individuals with type 2 diabetes. No changes were observed in prediabetes. The observed effects appear to depend on baseline metabolic status rather than acute substrate utilisation during cold exposure. These findings support the potential of cold exposure as an adjunct non-pharmacological therapy for type 2 diabetes, although further mechanistic studies and validation in larger cohorts are warranted. TRIAL REGISTRATION: ClinicalTrials.gov NCT05576025 FUNDING: Dutch Organisation for Knowledge and Innovation in Health, Healthcare and Well-being (ZonMw): 09120012010062.
引用
- Hashim D, Jörgensen JA, van de Weijer T, et al. Acute mild cold exposure with shivering reduces 24 h glucose levels in individuals with type 2 diabetes but not prediabetes. Diabetologia. 2026. PMID: 42474505. doi:10.1007/s00125-026-06809-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。